Khayyat YM. Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. World J Hepatol 2021; 13(12): 2150-2160 [PMID: 35070015 DOI: 10.4254/wjh.v13.i12.2150]
Corresponding Author of This Article
Yasir Mohammed Khayyat, FACP, FRCP (C), MBChB, Associate Professor, Department of Medicine, Umm Al Qura University, Al Abdiyah District, Makkah 13578, Saudi Arabia. email@example.com
Checklist of Responsibilities for the Scientific Editor of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
1Comparison was done using chi-square test of significance, with P-value of < 0.05 indicating statistical significance. DM: Diabetes mellitus; HTN: Hypertension; NFS: Nonalcoholic fatty liver disease fibrosis score.
Table 3 Agreement between FibroScan and nonalcoholic fatty liver disease fibrosis score among body mass index categories
NFS < -1.455
NFS > 0.676
κappa: Kappa statistic used with cP < 0.001. BMI: Body mass index; NFS: Nonalcoholic fatty liver disease fibrosis score.
Table 4 Logistic regression analysis for predictors of indeterminate score according to body mass index class within nonalcoholic fatty liver disease cohort